Your prediction
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | 0.000% | 1.316% | -13.191% | -15.385% | 13.821% | -56.497% | -91.037% |
| Pacira Pharmaceuticals | -0.990% | -0.990% | 5.820% | -7.407% | -7.407% | -48.454% | -61.905% |
| Twist Bioscience Corp | 6.790% | 24.297% | 23.842% | 50.519% | 82.406% | 277.695% | -55.004% |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat
